Skip to content This fund aims to deliver long-term capital growth by investing in equities of companies globally engaged in the healthcare and life sciences sectors. It allocates at least 70% of assets to equity securities of companies operating across pharmaceuticals, biotechnology, medical devices, healthcare services, and life sciences worldwide. The strategy employs fundamental bottom-up research focused on identifying high-quality healthcare companies with attractive growth prospects, innovative pipelines, and exposure to healthcare sector dynamics. Through diversified global healthcare equity investment emphasizing sector specialisation, the fund provides focused healthcare sector exposure, appropriate for thematic investors seeking healthcare innovation participation with acceptance of sector concentration risks. more
| Time Frame | Absolute | Annualised |
|---|---|---|
| 1-Year Return | +19.67% | +19.67% |
| 3-Year Return | +25.11% | +7.86% |
| 5-Year Return | +21.37% | +3.95% |
| 10-Year Return | +133.70% | +8.85% |
| All Time Return | +712.89% | +8.59% |
Link copied 
